0000000001140028

AUTHOR

European Liver And Intestine Association (Elita)

showing 1 related works from this author

Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study

2016

Background & Aims: All oral direct acting antivirals (DAA) have been shown to improve the liver function of patients with decompensated cirrhosis but it is presently unknown whether this clinical improvement may lead to the delisting of some patients. The aim of this study was to assess if and which patients can be first inactivated due to clinically improvement and subsequently delisted in a real life setting. Methods: 103 consecutive listed patients without hepatocellular carcinoma were treated with different DAA combinations in 11 European centres between February 2014 and February 2015. Results: The cumulative incidence of inactivated and delisted patients by competing risk analysis…

Simeprevirmedicine.medical_specialtyCarcinoma HepatocellularCirrhosisWaiting ListsSofosbuvirmedicine.medical_treatmentDelistingLiver transplantationGastroenterologyDirect acting antivirals03 medical and health sciencesLiver disease0302 clinical medicineModel for End-Stage Liver DiseaseSDG 3 - Good Health and Well-beingInternal medicinemedicineHumansCumulative incidenceCirrhosiLiver transplantationHepatologybusiness.industryLiver Neoplasms[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyHepatitis C Chronicmedicine.disease3. Good healthCirrhosis030220 oncology & carcinogenesisHCV030211 gastroenterology & hepatologyDirect acting antiviralLiver functionbusinessmedicine.drug
researchProduct